It has been demonstrated that MMR deficient gynecological cancer cells also accumulate mutations in repeat sequences of cell growth, pro-apoptotic, cell regulatory, DNA repair, and oncogenes. This evidence concerns the gene MRC1 and female reproductive organ cancer.